Tocilizumab Interactions
There are 425 drugs known to interact with tocilizumab, along with 8 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 59 are major, 358 are moderate, and 8 are minor.
- View all 425 medications that may interact with tocilizumab
- View tocilizumab alcohol/food interactions (1)
- View tocilizumab disease interactions (8)
Most frequently checked interactions
View interaction reports for tocilizumab and the medicines listed below.
- Acetylsalicylic Acid (aspirin)
- Aimovig (erenumab)
- Allegra (fexofenadine)
- Arava (leflunomide)
- Aspirin Low Strength (aspirin)
- Augmentin (amoxicillin / clavulanate)
- Bactrim (sulfamethoxazole / trimethoprim)
- Celebrex (celecoxib)
- CoQ10 (ubiquinone)
- Cymbalta (duloxetine)
- Diflucan (fluconazole)
- Eliquis (apixaban)
- Ethyl Alcohol (ethanol)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Heparin Sodium (heparin)
- Lipitor (atorvastatin)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Nexium (esomeprazole)
- Paracetamol (acetaminophen)
- Plaquenil (hydroxychloroquine)
- Quercetin (bioflavonoids)
- Symbicort (budesonide / formoterol)
- Tramadol Hydrochloride ER (tramadol)
- Tylenol (acetaminophen)
- Ventolin (albuterol)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Vitamin K2 (menaquinone)
Tocilizumab alcohol/food interactions
There is 1 alcohol/food interaction with tocilizumab.
Tocilizumab disease interactions
There are 8 disease interactions with tocilizumab which include:
- infections
- tuberculosis
- demyelinating disorders
- gastrointestinal perforation
- lipid abnormalities
- liver dysfunction
- neutropenia/thrombocytopenia
- renal impairment
More about tocilizumab
- tocilizumab consumer information
- Compare alternatives
- Reviews (57)
- Side effects
- Dosage information
- During pregnancy
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.